IL-17 plays a key role in a variety of autoimmune diseases. MCP-1 is involved in the infiltration of mononuclear cells of myocardium in VMC. However, the relationship between IL-17 and MCP-1 in myocardial injury remains unclear. In this study, expression of MCP-1 mRNA and protein in cardiac myocytes was detected with qRT-PCR and ELISA, respectively. It was found that IL-17A induced MCP-1 expression in a dose-and time-dependent manner in cardiac myocytes, which could be blocked by IL-17A and IL-17RA neutralizing antibodies. NF-kB p65 and p-p65 protein expression in cardiac myocytes was studied with western blotting. Rates of p-p65 in whole lysates and in nuclear lysates all increased in the first 15 min. Meanwhile, the amount of NF-kB p65 in whole lysates did not change, but the amount of NF-kB p65 in nuclear lysates increased in the first 15 min. Then the optimal sequence and concentration of NF-kB p65 siRNAs was selected. After transfection of 10 nM siRNA-2 of NF-kB p65 into cardiac myocytes before stimulation by IL-17A, expression of MCP-1 mRNA and protein obviously decreased. In conclusion, expression of MCP-1 induced by IL-17 requires NF-kB through the phosphorylation of p65 in cardiac myocytes, which is meaningful to study the onset of chronic viral myocarditis and will provide a new target for the treatment of viral myocarditis.
Viral myocarditis is a common disease which can cause myocardial damage among adolescents and young adults (1) . At present, there is no specific treatment for VMC. VMC is caused by viral infections such as coxsackievirus, echovirus, adenovirus, and picornavirus (2, 3) . It can lead to chronic myocarditis and dilated cardiomyopathy (4) . Immune responses caused by viruses are important in the pathogenesis of VMC, but excessive autoimmune responses are the main cause of myocardial cell damage in the progress of chronic myocarditis.
IL-17A is the most well-investigated member of the IL-17 family and is required for the onset of several diseases, such as rheumatoid arthritis, psoriasis and psoriatic arthritis (5) (6) (7) . Recent research has indicated that IL-17 is involved in infectious heart disease (8) . MCP-1 plays an important role in the migration of mononuclear cells (9) . Interaction between MCP-1 and its receptor CCR2 has participated in many inflammatory and infectious heart diseases (10) . It has been reported that MCP-1 is essential to experimental autoimmune myocarditis (11, 12) . However, whether IL-17 can regulate the expression of MCP-1 in cardiac myocytes and what are the transcription factors involved remain unclear.
NF-kB is the common nuclear transcription factor (13) (14) , and Wang et al. found that advanced oxidation protein products induced the expression of MCP-1 through the NF-kB signaling pathway in rat mesangial cells (15) . Thus, we conjecture that IL-17 regulates the expression of MCP-1 through the NF-kB pathway in cardiac myocytes, which is verified by siRNA to NF-kB in the present study. The mechanism of action of IL-17 on the expression of MCP-1 will provide a target for the treatment of VMC.
MATERIALS AND METHODS

Animals and reagents
Newborn (1 to 3 days old) BALB/c mice were purchased from the Henan Research Center of Experimental Animals in China. Fetal bovine serums were purchased from Hyclone (Logan, UT, USA). Recombinant mouse IL-17A was purchased from PeproTech (Rocky Hill, NJ, USA). Antibodies against IL-17A (E93203), IL-17RA (E11-12431C), NF-kB p65 (E18-0874-2), phospho-p65 NF-kB (E11-7171A) and GAPDH (E1A7021) were from EnoGene (Nanjing, China). Antibody against LaminB1 (3807-100) was from BioVision (Shanghai, China).
Primary cardiac myocytes culture
Neonatal BALB/c mice (1 to 3 days old) were humanely killed by ether inhalation. The heart was obtained aseptically, and minced in D-Hank's solution (Solarbio, Beijing, China). Tissues were incubated at 37°C in 0.1% Trypsin (Solarbio). After the tissues were digested, the supernatant was collected every 8 min and centrifuged immediately at 1000 rpm (168 g) for 10 min, excepting the first sample. The cells were dispersed, and suspended in DMEM/F12 (Hyclone) containing 20% FBS (Hyclone), then incubated at 37°C in 5% CO 2 for 90 min. Adherent cells were discarded, and cell suspensions were cultured at a density of 2 Â 10 4 -3 Â 10 4 cells/mL in DMEM/F12 containing 20% FBS at 37°C in 5% CO 2 . According to observation on shape and beat of the obtained cells, more than 95% of cells were identified to be cardiac myocytes.
RNA interference (RNAi) and transfection BALB/c mice p65 siRNA oligonucleotides (p65 siRNA-1 sense 5-GAAGCACAGAUACCACCAA-3; antisense 5-UUGGUGGUAUCUGUGCUUC-3; p65siRNA-2 sense 5-GGAGUACCCUGAAGCUAUATT-3; antisense 5-UAUAGCUUCAGGGUACUCCAT-3; p65siRNA-3 sense 5-GCGACAAGGUGCAGAAAGA-3; antisense 5-UCUUUCUGCACCUUGUCGC-3) and negative control (sense 5-UUCUCCGAACGUGUCACGUTT-3; antisense 5-ACGUGACACGUUCGGAGAATT-3) were synthesized by Ribobio (Guangzhou, China) and transfected into cardiac myocytes with siRNA-Mate TM (GenePharma Shanghai, China) following the manufacturer's instructions.
Real-time PCR
TRIzol reagent (Takara, Dalian, China) was used to extract total RNA from neonatal cardiac myocytes according to the manufacturer's instructions. Total RNA was reversed into cDNA by using a reverse transcription kit (Takara, Tokyo, Japan). Sequences of the primers are shown as follows: GAPDH (F: 5-CTGCACCAC-CAACTGCTTAG-3, R: 5-GTCTGGGATGGAAATT GTGA-3), MCP-1 (F: 5-CGGAATTCGCCACCATG-CAGGTCCCTGTCAT-3, R: 5-GCTCTAGACTAGTT-CACTGTCACACT-3) and P65 (F: 5-TGATGTGCA TCGGCAAGTG-3, R: 5-AGAAGTTGAGTTTCGGG-TAG-3). Real-time-PCR assay was carried out in a 20 mL volume containing 10 mL of 2 Â Taq MasterMix (With ROX) (CWBIO, Beijing, China). After the initial denaturation step at 94°C for 5 min, a three-step cycle procedure was carried out (denaturation 94°C, 45 s annealing 58°C, 45 s and extension 72°C, 60 s) for 30 cycles, and relative mRNA expressions were normalized to the level of GAPDH.
Enzyme-linked immunosorbent assay
Cardiac myocytes were treated with increasing concentrations of IL-17A (0-100 ng/mL) for 24 hr or stimulated with 50 ng/mL IL-17A for 0-24 hr. Levels of MCP-1 in the culture supernatants were measured with MCP-1 ELISA kits (BOSTER, Shanghai, China).
Western-blot analysis
Total protein was extracted by radioimmunoprecipitation assay (RIPA) buffer containing phenylmethanesulfonyl fluoride (PMSF). Lysates were centrifuged to remove cellular debris and protein concentration was measured using a BCA protein assay kit (CWBIO). NF-kB p65 and NF-kB phospho-p65 in whole lysates were extracted following the total protein extraction reagent (Bio-Rad, Shanghai, China) and pellets were further lysed in nuclear protein extraction reagent (BestBio, Shanghai, China) respectively. Protein sample (30 mg) was separated in 10% SDS-PAGE and then transferred to polyvinylidene fluoride NF-kB phospho-p65 for MCP-1 expression (PVDF) membranes (CWBIO). After blocking with blocking solution, primary antibodies against NF-kB p65, NF-kB phospho-p65 and GAPDH or LaminB1 were incubated with the membranes overnight at 4°C. Then HRP-conjugated secondary antibodies (ab97095; Abcam, Shanghai, China) were incubated with membranes for 2 hr and then the membranes were washed for 1 hr. GAPDH or LaminB1 was used as internal loading control. Densitometric quantification of the bands was done using Image J software (version 1.29Â; NIH, Bethesda, MD, USA).
Statistical analysis
Data are shown as mean AE SD calculated by two-tailed Student's t-test using SPSS 17.0 (SPSS Inc. Released 2008. SPSS Statistics for Windows, Version 17.0. SPSS Inc., Chicago, IL, USA). P < 0.05 was considered statistically significant. All experiments were carried out at least three times.
RESULTS
Expression of MCP-1 in a dose-and timedependent manner induced by IL-17A in cardiac myocytes
Cardiac myocytes were stimulated by IL-17A (0-100 ng/ mL) for 24 hr. When cells were treated with 1 ng/ml IL-17A, mRNA (Fig. 1a) and protein (Fig. 1b) expression of MCP-1 started to increase, and reached its peak at 100 ng/mL (mRNA expression P < 0.01 vs culture medium controls, protein expression P < 0.001 vs culture medium controls).
Cardiac myocytes were stimulated by 50 ng/mL IL-17A for 0-24 hr. mRNA expression of MCP-1 started to increase at 2 hr and reached the highest level at 4 hr (P < 0.01 vs culture medium controls) and then significantly decreased at 12 hr (P < 0.01 vs culture medium controls) and 24 hr (P < 0.05 vs culture medium controls) (Fig. 1c) . The protein level of MCP-1 started to increase at 6 hr and reached the highest level at 24 hr (P < 0.001 vs culture medium controls) (Fig. 1d) .
Expression of MCP-1 blocked by IL-17A or IL-17RA neutralizing antibodies in cardiac myocytes
Specificity of the response to IL-17A was abolished by IL-17A or IL-17RA neutralizing antibodies (10 ng/mL) for 1 hr before addition of IL-17A. After stimulation by IL-17A, the expression of MCP-1 increased in all groups (P < 0.001 vs corresponding group of controls). However, the expression of MCP-1 in the groups blocked by IL-17A or IL-17RA neutralizing antibodies was significantly less than that of the groups treated by controlled immunoglobulin (Ig)G (P < 0.001 vs the control IgG of the group stimulated by IL-17A) (Fig. 2) .
Expression of MCP-1 induced by IL-17A requires phosphorylation of NF-kB p65
Cardiac myocytes were stimulated by IL-17A (50 ng/ mL), and then the protein levels of NF-kB p65 and phospho-p65 of NF-kB in whole lysates and in nuclear lysates were detected by western blotting at different time points (0, 5, 15 and 30 min). There was no difference in the protein levels of NF-kB p65 among all groups in whole lysates (P > 0.05). However, the levels of phospho-p65 of NF-kB were increased at 5 min (P < 0.05 vs controls), and reached the highest level at 15 min (P < 00.05 vs controls), and then gradually decreased (Fig. 3a) . Then the protein levels of NF-kB p65 in nuclear lysates were increased at 5 min and 15 min (P < 00.05 vs controls). At the same time, the levels of phospho-p65 of NF-kB also increased at 5 min, and reached the highest level at 15 min (P < 00.05 vs controls), which was the same as the results in whole lysates (Fig. 3b) .
Optimal sequence and concentration for NF-kB p65 siRNAs
In order to research the role of NF-kB p65 in IL-17A-induced expression of MCP-1 by siRNA, three pairs of siRNA sequences targeting MCP-1 promoter sequence were designed, and qRT-PCR was used to detect the expression of whole-cell NF-kB p65 mRNA. Compared with culture medium controls, the interference groups including siRNA-1 group, siRNA-2 group and siRNA-3 group could downregulate the expression of NF-kB p65 mRNA. In particular, the siRNA-2 group showed the most interference efficiency (P < 0.05) (Fig. 4a) . Moreover 10 nM siRNA-2 could greatly interfere with the expression of wholecell NF-kB p65 mRNA (P < 0.05 vs culture medium controls) (Fig. 4b) .
Knocking down NF-kB p65 by NF-kB p65 siRNA-2 abolished IL-17A-induced expression of MCP-1 in cardiac myocytes
In order to study whether the activation of NF-kB plays a key role in IL-17A-induced expression of MCP-1, p65 siRNA-2 and negative siRNA were transfected into cardiac myocytes by siRNA-Mate (Gene Pharma, Shanghai, China). At 12 hr after transferring p65 siRNA-2 and negative siRNA, cardiac myocytes were treated with IL-17A. It was found that there was no significant difference in the mRNA and protein expression of MCP-1 between the negative siRNA group and culture medium controls (P > 0.05). Also, mRNA and protein of MCP-1 in the group treated with negative siRNA were significantly higher than that of the group treated with p65 siRNA-2 (mRNA expression P < 0.05, protein expression P < 0.001), which were still lower than the groups treated with negative siRNA þ IL-17A (mRNA expression P < 0.01, protein expression P < 0.001). When compared with the group treated with negative siRNA þ IL-17A, mRNA and protein of MCP-1 in the group treated with p65 < 0.001) (Fig. 5a,b) . This indicated that NF-kB was important in the upregulation of MCP-1 expression stimulated by IL-17A in cardiac myocytes. 
DISCUSSION
IL-17A is a cytokine that is mainly produced by activated Th17 cells. There is little similar homology between IL-17A and other members of IL-17 family (16). Upregulation of IL-17 occurs in many different autoimmune diseases (5-7). Myocarditis is characterized by inflammatory cell infiltration into the myocardium and subsequent deterioration of cardiac function (10). MCP-1 plays an important role in many inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (17) (18) (19) . Our previous research demonstrated that MCP-1 could enhance the migration of mononuclear cells into the myocardia of CVB3-infected mice. However, the relationship between IL-17 and MCP-1 in myocardial injury is unclear. In the present study, it was found that IL-17A upregulated the expression of MCP-1 in a dose-and time-dependent manner in cardiac myocytes. After stimulation by IL-17A, the expression of MCP-1 mRNA started to increase at 2 hr, and reached a peak at 4 h, and then significantly decreased at 12 hr and 24 hr. At the same time, the level of MCP-1 protein increased at 6 hr, and attained the highest level at 24 hr. Thus, we conjecture that the expression of mRNA may be prior to the protein expression. A few reports have indicated that IL-17 regulated target gene expression by activating NF-kB, and the importance of NF-kB in IL-17 signaling has been demonstrated in various disease models (20, 21) . In the present study, activation of NF-kB through phosphorylation of p65 was found after stimulation by IL-17A, rather than the upregulated expression of NF-kB p65. To further investigate whether NF-kB is indispensable for the expression of MCP-1 induced by IL-17 in cardiac myocytes, NF-kB p65 siRNA transfection was used to abolish NF-kB p65 in cardiac myocytes. The results showed that the expression of MCP-1 induced by IL-17A could be efficiently inhibited by NF-kB p65 siRNA. It demonstrated that the expression of MCP-1 induced by IL-17 required NF-kB through the phosphorylation of p65 in cardiac myocytes.
Pathogenesis of the chronicity of viral myocarditis is unclear. In the present study, it was identified that IL-17 could induce the expression of MCP-1 through the NFkB pathway in cardiac myocytes. However, other transcription factors and signal transduction pathways involved in the expression of MCP-1 induced by IL-17 will be further studied (22) (23) (24) . It is meaningful to study the onset of chronic viral myocarditis and this will provide a new target for the treatment of viral myocarditis by clarifying the molecular mechanisms of IL-17 on the expression of MCP-1 in myocardial cells. 
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